• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[遗传性血管性水肿。58例患者的家族史和临床表现]

[Hereditary angioedema. Family history and clinical manifestations in 58 patients].

作者信息

Romero Diego S Fernández, Di Marco Pamela, Malbrán Alejandro

机构信息

Servicio de Alergia e Inmunología Clínica, Hospital Británico de Buenos Aires, Argentina.

出版信息

Medicina (B Aires). 2009;69(6):601-6.

PMID:20053597
Abstract

Hereditary angioedema (HAE) is a rare autosomal dominant disease, characterized by episodes of edema typically involving the skin, gastrointestinal tract and larynx. We here describe the epidemiologic and clinical characteristic of a series of 58 patients with diagnosis of HAE, 53 (91%) type I and 5 (9%) type II. The mean age at first symptom was 10.8 +/- 9.5 years and the mean age at diagnosis was 25.8 +/- 16.2 years old, with a diagnosis delay of 15.3 +/- 14.3 years. The mean number of attacks in the previous 6 months was 7.4 +/- 7.6 range 0 to 40. Fifty four (93%) had cutaneous attacks, 50 (86%) abdominal attacks, 24 (41%) laryngeal attacks and 24 (41%) combined cutaneous and abdominal attacks. Twenty seven (46.5%) patients never received preventive treatments and 17 (29%) received danazol in different doses for different periods of time. During the attacks, 15 (26%) patients were treated with C1 inhibitor at least once, 7 (12%) with fresh frozen plasma and 40 (69%) received only supportive treatment. Stress and trauma were identified as attacks triggers. Six (10%) patients were first mutation and 52 (90%) had HAE ancestors. We reconstructed 20 kindred, identifying 205 individuals at risk of inheriting the disease, 109 (53 %) of them had signs or laboratory diagnosis of HAE. The total number of identified HAE individuals was 145, 19 (13%) died with asphyxia. So, shortening of diagnosis delay and appropriate treatment of HAE are a challenge to be fulfilled.

摘要

遗传性血管性水肿(HAE)是一种罕见的常染色体显性疾病,其特征是出现水肿发作,通常累及皮肤、胃肠道和喉部。我们在此描述了一系列58例诊断为HAE的患者的流行病学和临床特征,其中I型53例(91%),II型5例(9%)。首发症状的平均年龄为10.8±9.5岁,诊断时的平均年龄为25.8±16.2岁,诊断延迟时间为15.3±14.3年。前6个月发作的平均次数为7.4±7.6次,范围为0至40次。54例(93%)有皮肤发作,50例(86%)有腹部发作,24例(41%)有喉部发作,24例(41%)有皮肤和腹部联合发作。27例(46.5%)患者从未接受过预防性治疗,17例(29%)在不同时间段接受了不同剂量的达那唑治疗。发作期间,15例(26%)患者至少接受过一次C1抑制剂治疗,7例(12%)接受过新鲜冰冻血浆治疗,40例(69%)仅接受了支持性治疗。压力和创伤被确定为发作诱因。6例(10%)患者为首次突变,52例(90%)有HAE家族史。我们重建了20个家系,确定了205个有遗传该病风险的个体,其中109例(53%)有HAE的体征或实验室诊断。已确定的HAE个体总数为145例,19例(13%)死于窒息。因此,缩短HAE的诊断延迟并进行适当治疗是一项有待完成的挑战。

相似文献

1
[Hereditary angioedema. Family history and clinical manifestations in 58 patients].[遗传性血管性水肿。58例患者的家族史和临床表现]
Medicina (B Aires). 2009;69(6):601-6.
2
Molecular diagnosis and management of hereditary angioedema in a Greek family.一个希腊家族中遗传性血管性水肿的分子诊断与管理
Int Arch Allergy Immunol. 2008;147(2):166-70. doi: 10.1159/000137286. Epub 2008 Jun 6.
3
Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.遗传性血管性水肿致 C1-INH 缺乏患者的致命性喉部发作和死亡率。
J Allergy Clin Immunol. 2012 Sep;130(3):692-7. doi: 10.1016/j.jaci.2012.05.055. Epub 2012 Jul 28.
4
Diagnosis and treatment of hereditary angioedema.遗传性血管性水肿的诊断与治疗。
Panminerva Med. 2012 Sep;54(3):241-53.
5
[Clinical features of hereditary angioedema: analysis of 133 cases].遗传性血管性水肿的临床特征:133例分析
Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2772-6.
6
Novel and recurrent mutations in the C1NH gene of Arab patients affected with hereditary angioedema.阿拉伯遗传性血管性水肿患者 C1NH 基因中的新突变和复发突变。
Int Arch Allergy Immunol. 2010;151(2):149-54. doi: 10.1159/000236005. Epub 2009 Sep 15.
7
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.用于治疗急性遗传性血管性水肿发作的血浆衍生 C1 酯酶抑制剂浓缩物的群体药代动力学。
Ann Allergy Asthma Immunol. 2010 Aug;105(2):149-54. doi: 10.1016/j.anai.2010.06.005.
8
Sudden upper airway obstruction in patients with hereditary angioedema.遗传性血管性水肿患者的急性上呼吸道梗阻
Transfus Apher Sci. 2003 Dec;29(3):235-8. doi: 10.1016/j.transci.2003.08.007.
9
Type I hereditary angioedema in Taiwan -- clinical, biological features and genetic study.台湾的 I 型遗传性血管性水肿——临床、生物学特征和遗传学研究。
Asian Pac J Allergy Immunol. 2011 Dec;29(4):327-31.
10
The Turkish Hereditary Angioedema Pilot Study (TURHAPS): the first Turkish series of hereditary angioedema.土耳其遗传性血管性水肿初步研究(TURHAPS):首个土耳其遗传性血管性水肿系列研究。
Int Arch Allergy Immunol. 2011;156(4):443-50. doi: 10.1159/000323915. Epub 2011 Aug 10.

引用本文的文献

1
Hereditary angioedema with C1 inhibitor (C1-INH) deficit: the strength of recognition (51 cases).伴有C1抑制剂(C1-INH)缺乏的遗传性血管性水肿:识别力度(51例)
Braz J Med Biol Res. 2018 Nov 14;51(12):e7813. doi: 10.1590/1414-431X20187813.
2
[Diagnostics and exclusion of hereditary angioedema : a standarized approach for the practice].[遗传性血管性水肿的诊断与排除:实践中的标准化方法]
Hautarzt. 2012 Jul;63(7):567-72. doi: 10.1007/s00105-012-2388-x.